Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales in a Greek Tertiary Care Hospital in Athens, 2020 to 2023.

Antibiotics (Basel) · 2025 · PMC11939492 · PMID 40149050

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

In accordance with other studies that have shown an increasing trend in NDMs, constituting the predominant mechanism of resistance [ 10 , 16 ], in several regions in Greece, our study indicates a decrease in VIM from 15.4% in 2020 to 11.8% in 2024, with a simultaneously increase in NDM enzymes from 16.7% in 2020 to 26.4% in 2024, resulting in metallo-β-lactamases becoming second in carbapenemase prevalence among CPEs.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.